spacer
home > epc > Winter 2019
PUBLICATIONS

European Pharmaceutical Contractor

epc
Winter 2019

   
Text
PDF
bullet
Clinical data
Precision Medicine Challenges

Realising International Data Access through Data Collaborations

Randy Ramin-Wright and Le Vin Chin at Clinerion explain how gaining access to real-world data on a global scale does not have to be intimidating and can be readily achieved through the use of the latest consolidation technologies.
 
view
download pdf
Data Oversight and Integrity

Improving Quality Using Centralised Statistical Monitoring

With new regulations and the continuing importance of quality management over regulatory submissions, monitoring data integrity and oversight is pivotal to success. Thomas Underwood at Quanticate explains more.
 
view
download pdf
CRO Consolidation and Global Growth

Exploring Growth Strategies for Smaller CROs

The life sciences industry is no stranger to mergers and acquisitions, particularly when discussing midsized CROs. Zac Beda at Upsilon Global examines the practice and looks into the benefits.
 
view
download pdf
   
spacer



Published quarterly in
February, May,
August, and November

News and Press Releases

Signant Health Appoints Lawrence Miller as Chief Technology Officer

LONDON & PHILADELPHIA – June 13, 2019: Signant Health, formerly CRF Bracket, has appointed Lawrence Miller as Chief Technology Officer. Signant unites electronic Clinical Outcomes Assessment (eCOA), eConsent, Patient Engagement, Interactive Response Technology (IRT), Clinical Supply Management and Endpoint Quality into the industry’s most comprehensive patient-centric suite of technology solutions and services. An accomplished innovator, Miller brings unique vision and expertise to a Signant team already committed to advancing clinical research with its next-generation technology portfolio.
More info >>

White Papers

Clinical Trial Site Contracting: The Conservative, Progressive and Hybrid Models

DrugDev

For the last 20 years, pharmaceutical companies have turned to a variety of clinical outsourcing solutions to reduce costs and improve timelines, enabling them to focus on their core value of research and development. In today’s tightly competitive market, companies are constantly striving for ways to further cut costs and reduce study startup cycle times, while maintaining quality. One of the key cost factors in global R&D spending, estimated at around $102 billion per Kalorama market research, is the cost of conducting clinical trials. CRO’s, which account for about 30% of the total R&D spending, have risen to the challenge of the clinical, technical and administrative management of these trials. But some pharmaceutical companies question how much control to relinquish to vendor partners, especially in the legal arena, due to potential ramifications.
More info >>

Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement